T
he isolation of vancomycin-resistant enterococci (VRE) was first reported in 1988 (1, 2) . During the last 2 decades, VRE have become significant nosocomial pathogens worldwide, mainly due to their adaptability in hospital environments and the limited treatment options. Nine types of glycopeptide resistance determinants (vanA, vanB, vanC, vanD, vanE, vanG, vanL, vanM , and vanN) have been reported and well characterized on the basis of phenotypic and genotypic criteria (3) . The vanA and vanB genotypes predominate worldwide (3, 4) .
We first reported the vanM gene in a vancomycin-resistant Enterococcus faecium (VREm) clinical isolate from a teaching hospital in Shanghai in 2006 (5) . Subsequently, only a single study from Singapore has reported vanM-type VRE isolates (6) . Epidemiology data for strains with van determinants other than vanA and vanB remain rare. In this study, we investigated the prevalence of van and virulence genes in VREm strains isolated from 9 hospitals in Shanghai. Pulsed-field gel electrophoresis (PFGE) and multilocus sequence type (MLST) were also performed to elucidate the molecular epidemiology of these strains.
Seventy consecutive and nonduplicate VREm clinical strains were collected from 9 hospitals in Shanghai between 2006 and 2014. MICs of 10 antimicrobial agents (vancomycin, teicoplanin, linezolid, fosfomycin, ampicillin, erythromycin, levofloxacin, gentamicin, minocyline, and rifampin) were determined by agar dilution. Etest (bioMérieux) was used to determine the MICs of tigecycline. Susceptibility to daptomycin was determined by broth microdilution using Mueller-Hinton II broth (cation adjusted) supplemented with calcium 50 g/ml. Results were interpreted using the 2012 guidelines of the Clinical and Laboratory Standards Institute (www.clsi.org; Wayne, PA, USA). Due to the lack of an acknowledged fosfomycin breakpoint for E. faecium, we used the breakpoints of fosfomycin for Enterococcus faecalis proposed by the CLSI. E. faecalis ATCC 29212 was used as a quality-control strain for MIC determination.
Vancomycin resistance genes were detected by PCR amplification, as previously described (5) . The PCR products were sequenced to determine the particular van genotype. The presence of five virulence genes (asa1, gelE, cylA, esp, and hyl) was assayed by multiplex PCR, as described previously (7). PFGE analysis was performed using a contour-clamped homogeneous electric field (CHEF) mapper system (Bio-Rad, USA), as previously described (8) . Banding patterns were analyzed with BioNumerics software, version 5.0 (Belgium). Isolates were categorized into the same PFGE pulsotype group if they shared more than 80% similarity. MLST analysis was performed as described previously (9) . Alleles and sequence types (STs) were analyzed and determined via the MLST database (http://efaecium.mlst.net/). Clusters of related STs were grouped into clonal complexes (CCs) using the eBURST program, version 3 (http://efaecium.mlst.net/eburst/). (Fig. 1) .
The vanM-type E. faecium isolates showed similar antimicrobial susceptibility patterns to the vanA-type isolates. All 70 VREm isolates were resistant to vancomycin (MICs, 128 to Ͼ256 g/ml) and levofloxacin, and all were susceptible to linezolid, daptomycin, and tigecycline. The teicoplanin resistance rates were 71.1% (32/45) in vanM-type and 84.0% (21/25) in vanA-type VREm isolates. The gentamicin resistance rates were 64.4% and 76% in vanM-type and vanA-type isolates, respectively. No statistically significant differences in susceptibility to the 12 antimicrobial agents were observed between vanM-and vanA-type strains (Table 1).
Five different pulsotypes were found among the 70 VREm strains, and each pulsotype included strains from at least 2 different hospitals (Fig. 2) . By MLST analysis, 12 sequence types (STs) were identified, including ST 17 (n ϭ 3), ST 18 (n ϭ 2), ST 78 (n ϭ 46), ST 203 (n ϭ 2), ST 252 (n ϭ 1), ST 262 (n ϭ 2), ST 290 (n ϭ 1), ST 341 (n ϭ 1), ST 389 (n ϭ 1), ST 555 (n ϭ 7), ST 564 (n ϭ 3), and ST 881 (n ϭ 1). ST 881 is a new sequence type found in this study, and the data were uploaded to the eBURST database.
eBURST analysis showed that all of the 70 VREm isolates belonged to clonal complex (CC) 17.
The esp gene was present 97.8% (44/45) and 84% (21/25) of vanM-type and vanA-type isolates, respectively (P ϭ 0.033). The hyl gene was detected in 17.8% (6/45) and 32% (8/25) of vanMtype and vanA-type isolates, respectively (P ϭ 0.063). All strains were negative for the presence of cylA, gelE, and asa1 virulence genes. One of the reasons for the rarity of vanM-type VREm strains might be that most clinical laboratories and commercial molecular detection kits (Cepheid, Bouwel, Belgium; BD DiagnosticsGeneOhm, San Diego, CA) mainly focus on vanA and vanB genes and do not include the vanM gene (13, 14) . In a study conducted in Mexico, one isolate of E. faecium demonstrated high-level resistance to vancomycin and teicoplanin, but it was classified as non-vanA, non-vanB isolate (15) , which suggests that detection of new vancomycin resistance genes, such as vanM, might be missed based on current screening methods.
Overall, the results presented here suggest that vanM gene plays an important role in vancomycin resistance and dissemination in E. faecium strains in Shanghai. Therefore, it is necessary to screen for vanM in E. faecium strains to better control vanM-type VREm infection and dissemination.
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